DavidBFeinbloomMD

PubMed

• 1 citations
  Hospitalist Perceptions of Electronic Health Records: a Multi-site Survey.
  Zuzanna Czernik, Amy Yu, Jonathan Pell, David Feinbloom, Christine D Jones> ;Journal of General Internal Medicine. 2021 Jan 21
• 1 citations
  Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis
  David Feinbloom, Jason A. Freed, Alexander R. Carbo, Yoojin Jung, May Adra, Shoshana J. Herzig> ;Journal of Thrombosis and Thrombolysis. 2021 Jul 1
• 3 citations
  Resident Case Review at the Departmental Level: A Win-Win Scenario.
  Alexander R. Carbo, Elaine Goodman, Cheryle Totte, Peter Clardy, David Feinbloom, Hans Kim, Gila Kriegel, Meghan Dierks, Saul N. Weingart, Kenneth Sands, Mark D. Arons...> ;The American Journal of Medicine. 2016 Apr 1
• 12 citations
  Improving appropriateness of acid-suppressive medication use via computerized clinical decision support.
  Shoshana J. Herzig, Jamey Guess, David Feinbloom, May Adra, Kevin A. Afonso, Michael D. Howell, Edward R. Marcantonio> ;Journal of Hospital Medicine. 2015 Jan 1
• 3 citations
  Periprocedural management of antithrombotic therapy in hospitalized patients
  David Feinbloom> ;Journal of Hospital Medicine. 2014 May 1
• 24 citations
  Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients.
  Shoshana J. Herzig, Michael B. Rothberg, David Feinbloom, Michael D. Howell, Kalon K.L. Ho, Long Ngo, Edward R. Marcantonio> ;Journal of General Internal Medicine. 2013 Apr 16
• Erratum to: Risk Factors for Nosocomial Gastrointestinal Bleeding and Use of Acid-Suppressive Medication in Non-Critically Ill Patients.
  Herzig, S. J.,Rothberg, M. B.,Feinbloom, D. B.,Howell, M. D.,Ho, K. K.,Ngo, L. H.,Marcantonio, E. R.> ;J Gen Intern Med. 2013 Apr 17
• Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients
  David Feinbloom, Kenneth A. Bauer> ;Annals of Internal Medicine. 2012 Apr 17
• Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
  Buller HR Prins MH Lensin AW Decousus H Jacobson BF Minar E Chlumsky J Verhamme P Wells P Agnelli G Cohen A Berkowitz SD Bounameaux H Davidson BL Misselwitz F Gallus A...> ;N Engl J Med . 2012 Apr 5
• Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
  Bergmann JF Cohen AT Tapson VF Goldhaber SZ Kakkar AK Deslandes B Huang W Anderson FA Jr > ;Thromb Haemost . 2010 Apr
• 2 citations
  The role of other hemostatic factors in predicting arterial thrombotic events.
  David Feinbloom, Kenneth A. Bauer> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2006 Mar 1
• 91 citations
  Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
  David Feinbloom, Kenneth A. Bauer> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 Oct 1
• 4 citations
  Recommendations for management of community- and hospital-acquired pneumonia-the hospitalist perspective.
  Alpesh Amin, David Feinbloom, Susan Krekun, Joseph Li, Mary Pak, Daniel Rauch, Anne Borik> ;Current Opinion in Pulmonary Medicine. 2004 Nov 1
• Community- and hospital-acquired pneumonia-the role of the hospitalist in improving outcomes and reducing resource utilization.
  Alpesh Amin, Anne Borik, Ronald J. DeBellis, David Feinbloom, Susan Krekun, Joseph Li, Mary Pak, Daniel Rauch, Douglas B. Schwartz> ;Current Opinion in Pulmonary Medicine. 2004 Nov 1
• In-hospital initiation of lipid-lowering therapy: the role of the hospitalist.
  Alpesh Amin, Amir Ansari, Marc B. Blatt, Anne Borik, David Feinbloom, Susan Krekun, Joseph Li, Mary Pak, Sandhya Rao, Daniel Rauch> ;Critical Pathways in Cardiology. 2004 Sep 1
• Join now to see all